Robert Pennington
Internal Medicine · Durham, NCNPI 1144224080
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $795 and has fallen 97.7% since, to $18 in 2022.
Across 121 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$323
- Johnson & Johnson$175
- Takeda Pharmaceuticals U.S.A., Inc.$156
- Amgen$144
- Boehringer Ingelheim$133
- Pfizer$117
- plus $844 from 19 others
What the payments were for
- Food & beverage$1,891100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $323 |
| Johnson & Johnson | 10 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $156 |
| Amgen | 9 | $144 |
| Boehringer Ingelheim | 8 | $133 |
| Pfizer | 8 | $117 |
| Amarin Pharma, Inc. | 6 | $112 |
| AbbVie(2 entities) | 5 | $96 |
| Sanofi-aventis U.S. LLC | 5 | $72 |
| Lilly USA, LLC | 5 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $62 |
| GSK | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53 |
| IBSA Pharma Inc. | 3 | $52 |
| Merck | 4 | $50 |
| Bausch Health US, LLC | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $37 |
| Neos Therapeutics, LP | 2 | $26 |
| AstraZeneca | 2 | $26 |
| Eisai Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
| Gilead | 1 | $11 |
How this compares
$1,891 in reported general payments places this provider in the 80th percentile of 3,302 internal medicine providers in North Carolina.
Other internal medicine in Durham
- Nirmish ShahDurham$862K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Patricia LugarDurham$197K
- Rebecca RichDurham$160K
- Adam DevoreDurham$112K
- Kevin ThomasDurham$101K
- Julius WilderDurham$97K
- Richard RiedelDurham$95K
- Jennifer RymerDurham$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.